Market Cap : 829.91 M | Enterprise Value : 818.69 M | PE Ratio : 22.71 | PB Ratio : 10.19 |
---|
NAS:NRC has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:NRC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, National Research's Enterprise Value is $818.7 Mil. National Research's EBIT for the trailing twelve months (TTM) ended in Mar. 2022 was $50.0 Mil. Therefore, National Research's EV-to-EBIT ratio for today is 16.38.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, National Research's Enterprise Value is $818.7 Mil. National Research's EBITDA for the trailing twelve months (TTM) ended in Mar. 2022 was $55.7 Mil. Therefore, National Research's EV-to-EBITDA ratio for today is 14.70.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, National Research's Enterprise Value is $818.7 Mil. National Research's Revenue for the trailing twelve months (TTM) ended in Mar. 2022 was $150.9 Mil. Therefore, National Research's EV-to-Revenue ratio for today is 5.42.
The historical data trend for National Research's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, National Research's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, National Research's Enterprise Value distribution charts can be found below:
* The bar in red indicates where National Research's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
National Research's Enterprise Value for the fiscal year that ended in Dec. 2021 is calculated as
Enterprise Value (A: Dec. 2021 ) | |||||
= | Market Cap | + | Preferred Stock | + | Long-Term Debt & Capital Lease Obligation |
= | 1053.005328 | + | 0 | + | 22.269 |
+ | Short-Term Debt & Capital Lease Obligation | + | Minority Interest | - | Cash, Cash Equivalents, Marketable Securities |
+ | 4.278 | + | 0 | - | 54.361 |
= | 1,025.2 |
National Research's Enterprise Value for the quarter that ended in Mar. 2022 is calculated as
Enterprise Value (Q: Mar. 2022 ) | |||||
= | Market Cap | + | Preferred Stock | + | Long-Term Debt & Capital Lease Obligation |
= | 998.961925 | + | 0 | + | 21.161 |
+ | Short-Term Debt & Capital Lease Obligation | + | Minority Interest | - | Cash, Cash Equivalents, Marketable Securities |
+ | 4.333 | + | 0 | - | 47.29 |
= | 977.2 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
National Research's EV-to-EBIT for today is
EV-to-EBIT | = | Enterprise Value (Today) | / | EBIT (TTM) |
= | 818.691 | / | 49.994 | |
= | 16.38 |
National Research's current Enterprise Value is $818.7 Mil.
National Research's EBIT for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $50.0 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
National Research's EV-to-EBITDA for today is:
EV-to-EBITDA | = | Enterprise Value (Today) | / | EBITDA(TTM) |
= | 818.691 | / | 55.701 | |
= | 14.70 |
National Research's current Enterprise Value is $818.7 Mil.
National Research's EBITDA for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $55.7 Mil.
3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.
National Research's EV-to-Revenue for today is:
EV-to-Revenue | = | Enterprise Value (Today) | / | Revenue (TTM) |
= | 818.691 | / | 150.931 | |
= | 5.42 |
National Research's current Enterprise Value is $818.7 Mil.
National Research's Revenue for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $150.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of National Research's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Jackson Steven D. | officer: President | C/O NATIONAL RESEARCH CORPORATION 1245 Q STREET LINCOLN NE 68508 |
Martin Joann M | director | 6221 ANDREW COURT LINCOLN NE 68512 |
Nunnelly John N | director | P.O. BOX 2175 AMHERST MA 01004 |
Karas Kevin R | officer: SVP Finance, CFO, Treas & Secy | C/O NATIONAL RESEARCH CORPORATION 1245 Q STREET LINCOLN NE 68508 |
Berwick Donald M | director | C/O NATIONAL RESEARCH CORPORATION 1245 Q STREET LINCOLN NE 68508 |
Mowry Barbara | director | P.O. BOX 103115 DENVER CO 80250 |
Amandla Mk Trust | 10 percent owner | C/O THE BRYN MAWR TRUST COMPANY OF DELAW 20 MONTCHANIN RD, SUITE 100 GREENVILLE DE 19807 |
Hays Michael D. | director, officer: CEO | C/O NATIONAL RESEARCH CORPORATION 1245 Q STREET LINCOLN NE 68508 |
K/i/e Trust Under Agreement 10/24/18 | 10 percent owner | C/O BESSEMER TRUST COMPANY OF DELAWARE 1007 N. ORANGE ST., SUITE 1450 WILMINGTON DE 19801 |
Endacott Kent E. | 10 percent owner | C/O WOODS & AITKEN LLP 301 SOUTH 13TH STREET, SUITE 500 LINCOLN NE 68508 |
Beans Patrick E | director, officer: CFO and Secretary | AMANDLA LLC 709 PIER 2 LINCOLN NE 68528 |
Warden Gail L | director | 250 WASHINGTON RD GROSSE POINTE MI 48230 |
Henricks Susan L | officer: President and COO | C/O NATIONAL RESEARCH CORPORATION 1245 Q STREET LINCOLN NE 68508 |
Schorr Paul C Iii | director | PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: SCHORR PAUL C III a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;} |
Peetz Jeffery T | 10 percent owner | WOODS & AITKEN LLP 301 SOUTH 13TH STREET, SUITE 500 LINCOLN NE 68508 |
From GuruFocus
By Omar Venerio 11-04-2020
By GuruFocusNews 02-14-2022
By GlobeNewswire 02-14-2022
By Don Li2 11-02-2021
Other Sources
By Seekingalpha 2022-02-09